BP707T · Semester 7 · B.Pharm
Unit II — Regulatory Requirements in Drug Development
Regulatory Affairs
This study page introduces Regulatory Requirements in Drug Development in Regulatory Affairs (BP707T), B.Pharm Semester 7. Read the selected definitions and short notes below, then download the full unit PDF.
Topics in this unit
- Drug Discovery and Development Process and Teams
- Non-Clinical Drug Development
Definitions and short notes
Selected extracts from this unit’s notes. Download the full PDF below for the remaining topics and examples.
Drug discovery
The scientific process of finding a new chemical or biological substance that may become a medicine. It starts with an idea (for example, "this protein causes disease") and ends when one promising substance, called a drug candidate, is selected for detailed testing.
Unit PDF · page 2
Drug development
The process of testing the selected drug candidate — first in laboratories and animals, then in humans — to prove it is safe and effective, and finally getting permission from the regulatory authority to sell it. Development includes all clinical trials and the approval application.
Unit PDF · page 2
Download notes
Save the PDF for offline reading. On some browsers, the file opens first; use the PDF viewer’s download button to save it.
For education and exam preparation only, not medical advice or current regulatory guidance.